Rankings
▼
Calendar
NTLA FY 2014 Earnings — Intellia Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
NTLA
Intellia Therapeutics, Inc.
$2B
FY 2014 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$2M
Operating Income
-$5M
Net Income
-$14M
EPS (Diluted)
$-1.39
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$4M
Stock-Based Comp.
$462,000
Balance Sheet
Total Assets
$11M
Total Liabilities
$3M
Stockholders' Equity
$8M
Cash & Equivalents
$10M
← FY 2015
All Quarters
